liraglutide
liraglutide is listed in the FDA National Drug Code directory with 18 NDC codes, marketed under brand names including liraglutide, Victoza, Liraglutide. Available dosage forms: injection, solution, injection, powder.
Drug details
- Generic Name
- liraglutide
- Brand Names
- liraglutide, Victoza, Liraglutide, Saxenda
- Application Number
- ANDA217234
- Sponsor
- Orbicular Pharmaceutical Technologies Private Limited
- NDC Codes
- 18
- Dosage Forms
- INJECTION, SOLUTION, INJECTION, POWDER
- Routes
- SUBCUTANEOUS
- Active Ingredients
- LIRAGLUTIDE
Indications and Usage
1 INDICATIONS AND USAGE Liraglutide Injection is indicated: as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus. Limitations of Use : Liraglutide Injection contains liraglutide. Coadministration with other liraglutide-containing products is not recommended. Liraglutide Injection is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated: as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus ( 1 ). Limitations of Use : Coadministration with other liraglutide-containing products is not recommended.